New Delhi, Roohi Parvez. Covid Vaccine For Kids: Covaxin has become the first COVID-19 vaccine to be officially available for children in India. Authorities have given permission to Covaccine for emergency use. The vaccine, made by Hyderabad-based Bharat Biotech, has been recommended for use in children aged 2-18 years by the Subject Expert Committee (SEC), an expert panel on immunization in the country.
The SEC’s recommendations have been submitted to the Drug Controller General of India (DGCI), which gives the final approval.
What is said in the official statement
The SEC’s statement said: “After detailed deliberation, the committee recommended approval to market authorization of the vaccine for the age group of 2 to 18 years for restricted use in the event of an emergency.”
How effective will Covaccine be on children?
Covaccine, which is an inactive virus vaccine, was approved for adults in India last year. Covaccine provides 71 percent effective efficacy against SARS-COV-2 virus and its variants. While the vaccine is still undergoing clinical trials, the developers started their clinical trials at select AIIMS centers across the country to test the vaccine’s efficacy on underage children. However, it is not yet known when the vaccine will be available for use in children.
Dr. Tripti Gilada, Infectious Disease Specialist at Masina Hospital, Mumbai, says, “The vaccine efficacy has been found to be similar to what has been observed in adults. More importantly, the vaccines are extremely safe. WHO in a week We are expected to see the beginning of the final phase of the fight against COVID-19. With the vaccination of children, we can expect the schools to be fully functional in January. Will be able to open again. Now we just need to speed up vaccine production. During the initial phase of the vaccine, the hesitation that people had about the vaccine should not be seen in the case of children because India has a very successful tradition of immunization of children Is.”
Guidelines for Emergency Vaccinations
In many countries, young children have also started getting the vaccine. In such a situation, it is necessary for children to get the vaccine to avoid the third wave of Kovid-19 in India too. Like many other countries, children living in India will also be given equal priority to the Kovid-19 vaccine. However, the SEC’s recommendation is subject to certain conditions.
Covaccine may help protect children before third wave
Since the fury of the second wave, it is being said that the children of the third wave may be the most victims. This is because by then a large proportion of adults will have been vaccinated. In such a situation, getting approval of Covaccine is considered a commendable step. In addition to Covaccine, ZyCOV-D is also being developed for children. This is a DNA Kovid-19 vaccine, which will first be administered to young children.